Navigation Links
JCI table of contents: March 20, 2008
Date:3/20/2008

BACTERIOLOGY: Antibodies protect against bacteria in the blood

In developed countries, infection with nontyphoidal strains of Salmonella bacteria (NTS) usually occurs through eating contaminated food and causes gastroenteritis. By contrast, in Africa, children under the age of 2 and HIV-infected adults usually develop an infection in the blood (bacteremia), which is fatal in almost a quarter of affected children. There is currently no vaccine against NTS and understanding the immune response that protects against NTS bacteremia is crucial if one is to be developed. New data, generated by Calman MacLennan and colleagues, has now identified a role for antibody in protection against NTS bacteremia in children from Malawi, leading to the suggestion that effective vaccines against NTS should induce the generation of protective antibody.

TITLE: The neglected role of antibody in protection against bacteremia caused by nontyphoidal strains of Salmonella in African children

AUTHOR CONTACT:
Calman A. MacLennan
University of Birmingham, Birmingham, United Kingdom.
Phone: 44-121-414-6944; Fax: 44-121-414-3599; E-mail: c.maclennan@bham.ac.uk.

View the PDF of this article at: https://www.the-jci.org/article.php?id=33998


GENE THERAPY: Take heed: HOXB4 gene therapy causes leukemia in large animals

Individuals with a number of life-threatening genetic diseases of the immune system have been successfully treated by gene therapy that is, they were infused with early precursors of immune cells that had the correct form of the defective gene delivered into them by agents known as retroviral vectors. However, some patients later developed leukemia. This slowed progress in the field and has led to detailed studies seeking to determine the mechanisms underlying the cause of leukemia an
'/>"/>

Contact: Karen Honey
press_releases@the-jci.org
215-573-1850
Journal of Clinical Investigation
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Blue Cross and Blue Shield of Illinois Announces 2007 Charitable Donations
2. GSK Charitable Support Valued at $564 Million in 2007
3. JCI online early table of contents: March 13, 2008
4. Implantable medical devices may expose patients to security, privacy risks; solutions suggested
5. Perrigo Company to Market Over-the-Counter Cetirizine Hydrochloride, Pseudoephedrine Hydrochloride Extended-Release Tablets
6. Perrigo Company Announces Initial Shipments of Store Brand Omeprazole Tablets
7. V8 V-Fusion(R) Takes an Exotic, Tasty Twist on Vegetable Juice
8. JCI online early table of contents: March 3, 2008
9. AXA Equitable Meets the Needs of Two People under One Life Insurance Policy
10. Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
11. Nurses Convince Hospital to Return to Bargaining Table

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...to overlook needed care, study finds , ,... depression can worsen her child,s asthma, U.S. re...f 262 black mothers and their children found that ...s had more frequent asthma symptoms, while childre...ss frequent asthma symptoms. , The Johns Hopkin...
(Date:11/25/2009)...ONSkincare ®isproudtosupportGNC,seffortstorai...t.Jude ThanksandGiving campaign,$1fromthepurchasep...Balm willbedonatedtoSt.Jude.Additionally,GNCcustom...eckoutatoneoftheir5,000+retaillocationsoratGNC.com...heir2009 ThanksandGiving campaign. ,, "Wearedel...
(Date:11/25/2009)...ried into the body on a carefully engineered, fing...eliminate tumors in mammals, scientists report thi...ine . , The new approach, pioneered by bioengine...plastic disks impregnated with tumor-specific anti... mammalian immune system to attack tumors. The new...
(Date:11/25/2009)...tumor cells, study finds , , WEDNESDAY, ...ered in a fingernail-size implant eliminated melan...method uses polymer disks, 8.5 millimeters in diam... and implanted under the skin to reprogram the imm...y scientists who developed the implant predicted t...
(Date:11/25/2009)...ds to include cost-effective, sustainable distance...rofessionals in developing world. , ...9 -- Elluminate, Inc. , the leader in web, audio...ort 21st century teaching, learning, and collabora...iative was awarded iNACOL,s first-ever Outstandin...
Breaking Medicine News(10 mins):Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
... BOSTON Since the days of Hippocrates, people hav...e seasons. More recently, researchers have learned...s seasonality, are often related to the weather. I...he Department of Public Heath and Family Medicine ...
...OS GATOS, Calif., Sept. 12 Death may be the last ...ked about. It is usually looked,upon as something ...but,Philip and Darlyne intend to tear down the wal...ng death and Philip,s loss. They have written this...
...Using all natural guacamole as a dip or condiment ... - September 16 , November 14)-, DALLAS, Sept. 12...inking -- avocados are great for you. (Photo: ht... -- and loaded with lutein which protects,against ...
...ONTREAL, Sept. 12 /PRNewswire/ - The Montreal-base... (ISIVF) will host the 14th World,Congress on In V...ess on,In-Vitro Maturation (IVM), at the Fairmont ...ogists in the field of,human fertility. "As IVF a...
...aiser Family Foundation: Premiums increased at slo...h insurance,premiums increased at the slowest pace...ar premium increases have declined, according to a...nnual Survey found,that health insurance premiums ...
...ACKSONVILLE, Fla., Sept. 11 In remarks presented ...,s (BCBSF) annual,policyholders, meeting, Chris Do...e Officer and Chief Financial Officer, reported th...(Logo: http://www.newscom.com/cgi-bin/prnh/200004...
Other Medicine News:Health News:Mathematics might save you a trip to the ER 2Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2Health News:Guacamole: Fights Hunger, Cholesterol and Cancer 2Health News:World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress 2Health News:Health Insurance Premium Growth Slows for Fourth Straight Year 2Health News:Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance 2
(Date:11/25/2009)...wswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),...overing,developingandcommercializingnoveldrugstotr...iscalyearendedSeptember30,2009.AtSeptember30,2009P...shortterminvestments. ,, PipelineUpdateand2009...,, InlateNovember2009,anindependentDataMonitori...
(Date:11/25/2009)...e/--BioTrendsResearchGroup,Inc.releasedWave1ofits ...ulti-phasesyndicatedmarketresearchprojecttrackingt...ctlaunchthroughthefirstsixmonthsofavailability.Eac...m75uniqueDermatologistsandqualitativeinformationfr...,obstaclestouse,typicalpatienttypes,productpercept...
(Date:11/25/2009)...ewswire-USNewswire/--RemediumTechnologiesInc.,acom...ebleeding,wonfirstprizeand$10,000intheMostPromisin...009,companyofficialsannouncetoday. ,, Selectedf...teampitchedtheirinventionattheGSCSecuritySummitcon...dium( www.remediumtechnologies.com )isdevelopingah...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Group B Strep Screening Guidelines Sparing Newborns 49294 1Group B Strep Screening Guidelines Sparing Newborns 49294 2Group B Strep Screening Guidelines Sparing Newborns 49294 3Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 1Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 2Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference 12680 1
...he Food and Drug,Administration (FDA) Cardiovascul...Drug Safety and Risk Management Advisory Committee...to erythropoiesis-stimulating,agents (ESA,s), Orth... key,issues that will be discussed: * The studies...luated hemoglobin targets above 13 grams per de...
...lerability with No Clinically Significant ...erence Call Scheduled for 8:30AM (ET) Today-, PRI... VRUS ) is presenting safety, tolerability, pharma...cending doses of R7128 at the 14th,International S...being held,from September 9-13, 2007 in Glasgow, S...
Other Medicine Technology:Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 2Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 3Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 4Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 5Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 2Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 3Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 4Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 5
Diamond Burr - Round
Pterygium Diamond Burr
Ruedemann Lacrimal Dilator
Wilder Lacrimal Dilator - Long
Medicine Products: